Mice on O304-0.25 showed evidence of reduced insulin levels and reduced insulin resistance, i.e., HOMA-IR, already after 1 month of treatment compared with that at start and CD-fed mice (Fig. 3b–d). This evidence concerns the gene INS and Insulin resistance.